Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE launches annual award to honour changemakers
UAE becomes second country to approve Lipfendra to treat high cholesterol
Sharjah Police recovers AED 500,000 in stolen goods in under 3 hours
UAE welcomes Gaza agreement for Hamas disarmament
Sheikh Abdullah meets UK Foreign Secretary in London
H.H. Sheikh Hamdan attends GCC joint military drill in Bahrain
UAE President discusses regional developments with Syrian counterpart
UAE strongly condemns renewed Iranian hostile attack on Kuwait
